In-vitro Inhibitory Effect of Arsenic Trioxide on Human Lung Adenocarcinoma and Its Therapeutic Mechanism
- VernacularTitle:亚砷酸对人肺腺癌细胞的体外抑制作用及机制研究
- Author:
Xiaowei YE
;
Ting CHENG
;
Yao CHEN
;
Huili YE
;
Linxiang CHEN
;
- Publication Type:Journal Article
- Keywords:
ARSENOLITUM/pharmacology;
ARSENIC TRIOXIDE/pharmacology;
LUNG NEOPLASMS/TCDtherapy;
CELL APOPTOSIS;
CELL CULTURE;
GENE EXPRESSIONREGULATION
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2001;0(03):-
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To explore the therapeutic mechanismof arsenic trioxide(AS2O3),the active component of arsenolitumininhibitingtumor.【Methods】Humanlung adenocarcinoma cells(LAC) at logarithmic growth phase were culturedin vitro for 24 hours,and then were cocultured with arsenic trioxide(AS2O3) in the dosages of 0.75,1.0,1.5 and 2.0 mg/Lrespectively.Meanwhile,model control group was set up.The morphological features of LAC in different groups were observed under reverse microscope,growth-inhibitory rate of LAC was examined by methylthiazolyltetrazolium(MTT) assay,andthe expression of p53 gene was detected by enzyme-linked immunosorbent assay(ELISA) method.【Results】AS2O3in different dosages obviously inhibited the proliferation of LACin a time-effect manner,and markedly increased the expression of p53 gene(P
